Why did AMN Healthcare Services (AMN) stock move recently?

On 7/28/2026, AMN Healthcare Services moved +3.7% — AMN Healthcare Services rose 3.71% with no company-specific news, earnings, guidance, or filings on July 28; the move appears to reflect broader market or sector trends. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is AMN Healthcare Services (AMN) overvalued or fairly valued?

MarketChacha shows AMN Healthcare Services's valuation in context — a forward P/E of about 36.8, a price-to-book of about 1.8 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is AMN Healthcare Services's revenue?

AMN Healthcare Services reported revenue of $2.7B for FY2025, with net profit of $-95.7M, per official filings.

What is the share price of AMN Healthcare Services (AMN)?

AMN Healthcare Services last traded at $34.54 (+0.1% on the day), as of 8/17/2026 — a delayed quote shown for education, not investment advice.

AMN Healthcare Services

AMN · NYSE · Healthcare · United States

Snapshot

TickerAMN

ExchangeNYSE

SectorHealthcare

IndustryMedical Care Facilities

CountryUnited States

Employees2,664

HeadquartersDallas, United States

Websitewww.amnhealthcare.com

Filings tracked17

About AMN Healthcare Services

AMN Healthcare Services, Inc. provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. It offers travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, allied staffing, crisis nurse staffing for critical staffing and rapid response nursing, and allied health professionals, such as skilled nursing facilities, rehabilitation clinics, schools, and pharmacies, as well as physician and advanced practice staffing, and revenue cycle solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists; and solutions for schools, including teletherapy platform, Televate, and qualified school speech-language pathologists, psychologists, nurses, social workers, and other care providers. In addition, it offers locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. Additionally, the company provides language services, vendor management systems, workforce optimization, and outsourced solutions. The company offers its services under the brands, including AMN Healthcare, Nursefinders, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is based in Dallas, Texas.

Who owns it

Insiders1.0%
Institutions99.0%
Public & other0.0%

393 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.17.15%
Morgan Stanley5.89%
Vanguard Capital Management LLC4.44%
State Street Corporation4.37%
Boston Partners4.32%
Two Sigma Investments, LP4.10%
Arrowstreet Capital, Limited Partnership3.59%
Vanguard Portfolio Management LLC3.33%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

Margin has compressed by about 9.1 points over the period — profitability is trending down.

Net margin trend5.6% → -3.5%

Margin has compressed by about 9.1 points over the period — profitability is trending down.

Return on equity-14.9%

Latest ROE of -14.9% is on the low side — the business earns a modest return on shareholder capital.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $651.3M · EPS 0.21

Est. earnings growth -5.6%

Next fiscal year

Rev $2.7B · EPS 0.94

Est. earnings growth -71.5%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$2.7B

Net margin

-3.5%

ROE

-14.9%

Revenue CAGR (2y)

-15.1%

EPS (FY2025)

-2.48

Net profit (FY2025)

$-95.7M

Ask MarketChacha about AMN

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Jul 28, 2026
AMN Healthcare Services rose 3.71% with no company-specific news, earnings, guidance, or filings on July 28; the move appears to reflect broader market or sector trends.
· confidence: low
Jul 23, 2026
AMN shares fell 3.28% with no company-specific news or filing released today; the move appears to reflect broader market or sector trading.
· confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$2.7B	$-95.7M	-2.48	-3.5%	-14.9%
FY2024	$3.0B	$-147.0M	-3.85	-4.9%	-20.8%
FY2023	$3.8B	$210.7M	5.36	5.6%	25.3%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$673.2M	$21.2M	0.53	3.1%
2026Q1	$1.4B	$62.2M	1.59	4.5%
2025Q3	$634.5M	$29.3M	0.76	4.6%
2025Q2	$658.2M	$-116.2M	-3.02	-17.7%
2025Q1	$689.5M	$-1.1M	-0.03	-0.2%
2024Q3	$687.5M	$7.0M	0.18	1.0%
2024Q2	$740.7M	$16.2M	0.42	2.2%
2024Q1	$820.9M	$17.3M	0.45	2.1%
2023Q3	$853.5M	$53.2M	1.39	6.2%
2023Q2	$991.3M	$60.9M	1.55	6.1%
2023Q1	$1.1B	$84.1M	2.02	7.5%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q filing
SEC8/7/2026
8-K — Exhibits
SEC8/6/2026material
10-Q filing
SEC5/8/2026
8-K — Exhibits
SEC5/7/2026material
8-K — Executive/director change, Shareholder vote results, Exhibits
SEC5/4/2026material
10-K filing
SEC2/20/2026
8-K — Exhibits
SEC2/19/2026material
8-K — Executive/director change
SEC2/5/2026material
8-K — Reg FD disclosure
SEC1/14/2026material

2025

8-K — Bylaw/charter change
SEC12/11/2025material
10-Q filing
SEC11/7/2025
8-K — Results of operations, Exhibits
SEC11/6/2025material
8-K — Material agreement, Material financial obligation, Other events, Exhibits
SEC10/6/2025material
8-K — Reg FD disclosure
SEC9/22/2025material
8-K — Other events, Exhibits
SEC9/22/2025material
10-Q filing
SEC8/8/2025
8-K — Results of operations, Exhibits
SEC8/7/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.